Table 2.
Time After Injection, h
|
|||
---|---|---|---|
24 | 48 | 72 | |
%NENH vessel wall of ApoE−/− mice | |||
MDA2 micelles (n=8) | 60±9* | 90±3* | 125±22* |
E06 micelles (n=8) | 93±54* | 88±7* | 231±40* |
IK17 micelles (n=3) | 82±40* | 95±49* | 138±35* |
IgG micelles (n=3) | 3±33 | −8±9 | −0.6±29 |
Untargeted micelles (n=8) | 20±18 | 2±20 | 15±10 |
Competitive inhibition (n=3) | 43±24 | 33±18 | 20±15 |
%NENH in liver of ApoE−/− mice | |||
MDA2 micelles (n=8) | 34±18 | 34±7 | 33±4 |
E06 micelles (n=8) | 39±10 | 40±9 | 49±17 |
IK17 micelles (n=3) | 27±6 | 42±10 | 38±6 |
IgG micelles (n=3) | 27±10 | 10±9† | −4±4‡ |
Untargeted micelles (n=8) | 38±5 | 42±5 | 39±10 |
Competitive inhibition (n=3) | 8±3† | −8±8* | −8±8† |
P<0.001,
P<0.01,
P<0.05 vs untargeted micelles.